Modular Medical awards Felsher 25 common shares

The option was fully vested and exercisable on the grant date, with a $1.95 exercise price and a September 30, 2036 expiration.

Rhea-AI Filing Summary

Modular Medical, Inc. director Steven G. Felsher acquired 25 common shares under the company’s Outside Director Compensation Plan on September 30, 2026; his reported direct common-share position afterward was 8,538 shares, reflecting the 1-for-30 reverse stock split effected March 31, 2026. He also received an option for 250 shares, fully vested and exercisable on the grant date at a $1.95 exercise price and expiring September 30, 2036; the reported post-grant total for that derivative-security class was 250 options.

Insider Trade Summary

Grant/Award: 275 shares

Grant/Award 2 txns

Insider FELSHER STEVEN G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock F3, F4	250	--	--
Grant/Award	Common Stock F1, F2	25	--	--

Holdings After Transaction: Option to purchase common stock — 250 contracts (Direct); Common Stock — 8,538 shares (Direct)

Footnotes (4)

1. F1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
2. F2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.
3. F3. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
4. F4. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Common shares acquired: 25 shares Direct common shares following award: 8,538 shares Options granted: 250 options +2 more

5 metrics

Common shares acquired 25 shares Issued under the Outside Director Compensation Plan on September 30, 2026

Direct common shares following award 8,538 shares Reported after the September 30, 2026 transaction; reflects the 1-for-30 reverse stock split effected March 31, 2026

Options granted 250 options Granted September 30, 2026; reported post-grant total for that derivative-security class

Option exercise price $1.95 per share Option granted September 30, 2026

Option expiration September 30, 2036 Option granted September 30, 2026

Key Terms

Outside Director Compensation Plan, fully vested and exercisable, derivative security, reverse stock split

4 terms

Outside Director Compensation Plan financial

"pursuant to the Issuer's Outside Director Compensation Plan"

fully vested and exercisable financial

"the option was fully vested and exercisable on the grant date"

derivative security financial

"total beneficial ownership of the class of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

reverse stock split technical

"impact of a 1-for-30 reverse stock split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many common shares did MODD director Steven G. Felsher receive?

Steven G. Felsher received 25 common shares on September 30, 2026, under Modular Medical’s Outside Director Compensation Plan. His reported post-transaction direct common-share position was 8,538 shares, reflecting the impact of the 1-for-30 reverse stock split effected March 31, 2026.

What are the terms of Steven G. Felsher’s MODD option grant?

Felsher received an option to purchase 250 shares at a $1.95 exercise price. It was fully vested and exercisable on September 30, 2026, and expires September 30, 2036; the reported total beneficial ownership of that derivative-security class after grant was 250 options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 06:42 PM Accepted by SEC EDGAR 10/01/2026 - 06:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FELSHER STEVEN G

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC.

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2026		A		25	A	(1)	8,538(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$1.95	09/30/2026		A		250		09/30/2026	09/30/2036	Common Stock	250	(3)	250(4)	D

Explanation of Responses:

1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

3. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

4. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	/s/ James Sullivan, attorney-in-fact for Steven Felsher	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)